News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Cambridge Biotech TCR2 Therapeutics Launches From Stealth Mode With $44.5 Million     12/8/2016
The Franchise That Could Bring in Another $20 Billion for Celgene (CELG)     11/23/2016
Gilead (GILD) Suffers Another R&D Setback as Myelofibrosis Drug Flops in Phase III, Gives Credence to Acquisition Urgency     11/18/2016
China Takes Lead in CRISPR Race, Will Test on a Human for the First Time     11/16/2016
Little-Known Ganymed Grabs a $1.4 Billion Buyout Deal From Astellas (ALPMY)     10/31/2016
FDA Slaps Partial Hold on Bay Area Firm Aduro Biotech (ADRO)'s Cancer Vaccine Trial     10/25/2016
How Fast Can Kite Pharma (KITE) File for an Approval of its Lead CAR-T?     10/20/2016
3 Biotechs With Cancer Drugs That Could Win Approval in 2017     10/14/2016
ESMO 2016 Takeaways: Don't Miss Celldex (CLDX), Exelixis (EXEL) and Tesaro (TSRO)     10/13/2016
Tiny Crescendo Biologics Hammers Out $790 Million Immuno-Oncology Deal With Biotech Giant Takeda (TKPYY)     10/11/2016
How Struggling Ariad (ARIA) Used a Safety Problem to Quietly Raise Cancer Drug Price     10/7/2016
Deaths Lead Boehringer Ingelheim to Cancel $730 Million Cancer Deal With Hanmi Pharma (128940.KS), Hanmi Stock Tanks     10/6/2016
A Closer Look at the Pipelines Pfizer (PFE) Inherited From Recent Acquisitions     10/5/2016
Biotech Giant Amgen (AMGN) Forges $410 Million R&D Pact With Tiny Nuevolution     10/5/2016
New Startup Carrick Therapeutics Launches With $95 Million and Taps Former AstraZeneca PLC (AZN)-Eli Lilly (LLY) Exec as CEO     10/4/2016

News from Around the Web
From Smart Toothbrushes To Cancer, Royal Philips Electronics N.V. (PHG) Bets Big On Software     12/7/2016
At What Cost? Weighing A Cure For Cancer Against Its Pricetag     12/6/2016
French Cancer Specialist Innate Pharma (IPH.PA ) Can Remain Independent, For Now: CEO     11/28/2016
Do Cancer Clinical Trials Exaggerate The Real-World Benefits Of Drugs?     11/21/2016
3 Things Comeback Kid Exelixis (EXEL) Needs to Do to Succeed in 2017     11/18/2016
One CEO's Push To Make Cancer Drugs And Condoms Great Again     11/17/2016
Muscle-Wasting In Cancer Patients Could Be Diagnosed Earlier With New Tool, McGill University Study     11/9/2016
Novel System To Get Dying Patients An Experimental Cancer Drug Raises Hopes — And Thorny Questions     11/8/2016
Magic Johnson's HIV Story Offers Hope For Cancer Patients     11/8/2016
Does Johnson & Johnson (JNJ)'s Baby Powder Cause Cancer? Another Jury Says Yes     10/31/2016
Oral Cancer Rates Going Up For U.S. Men; Link To HPV Is Eyed     10/31/2016
Thousands More Patients Will Soon Be Able to Use IBM (IBM)'s Watson To Fight Cancer     10/31/2016
This New Nanotechnology Could Become the Next Major Cancer Breakthrough, Cold Spring Harbor Laboratory Study     10/27/2016
Roche (RHHBY) Bets On New Cancer Drugs To Offset Patent Expiries     10/21/2016
In Boston, Vice President Joe Biden Touts Progress Toward Curing Cancer     10/20/2016

Press Releases
NantHealth (NH), NantKwest And Nantomics Announce Availability Of GPS Cancer And Phase I – III QUILT Trials Through The U.S. NantKwest’s Clinicaltrials.Gov     12/8/2016
BerGenBio AS Release: New Breast Cancer Research Highlights BGB324 In Overcoming Immunotherapy Resistance     12/8/2016
Thermo Fisher Scientific (TMO) Launches Center Of Excellence In Immunotherapy Program     12/8/2016
ALOPEXX Oncology Presents Encouraging Results Of A Phase I Study Of DI-Leu16-IL2 In Relapsed/Refractory NHL At The American Society of Hematology Annual Meeting     12/7/2016
FDA Approves Genentech (RHHBY)’s Avastin (Bevacizumab) Plus Chemotherapy For A Specific Type Of Advanced Ovarian Cancer     12/7/2016
Progenics (PGNX) Announces First Patient Dosed In Phase II/III Clinical Trial Of PSMA-Targeted PET/CT Imaging Agent PyL     12/7/2016
ISA Pharmaceuticals Advances Personalized Cancer Treatment     12/7/2016
NantHealth (NH) And Transmed Systems Partner To Enable And Inform Community Oncologists Of The Most Effective Tools And Technologies For Personalized Cancer Treatments Using GPS Cancer     12/7/2016
Labcyte Inc. Announces Collaboration With Notable Labs To Apply Functional Cancer Cell Screening To Help Clinicians Individualize Patient Care     12/7/2016
MD Anderson Cancer Center And NIH To Fund Clinical Trial Combining Two Proprietary Mesoblast Technologies For Rapid Engraftment Of Stem Cell Transplants In Cancer Patients     12/7/2016
H3 Biomedicine Announces Data From Lead Development Program Of H3B-8800 In Pre-Clinical Models Of Hematologic Cancers     12/6/2016
Janssen Pharmaceutical Release: New Analysis Shows People With Cancer Who Received XARELTO (Rivaroxaban) For Blood Clots Had Fewer ER Visits And Lower Healthcare Costs Than Those Given Standard Treatment     12/6/2016
BioLineRx Presents Positive Phase 2a AML Study And Mechanism-Of-Action Data For BL-8040 Oncology Platform At American Society of Hematology 2016     12/5/2016
Immune Design Corporation (IMDZ) Provides Update From Two Discovery Platforms: DC-Tropic Zvex Delivering Multiple Tumor Antigens (Conserved And Neo-Antigens) And G100 For Intratumoral Immunotherapy     12/5/2016
Celldex (CLDX) Presents Data On CDX-1140, A Novel CD40 Agonist Antibody For Hematologic And Solid Malignancies, At The American Society of Hematology Annual Meeting     12/5/2016